In Parasitic infections Unicarbazan 50 mg/1.25 mg Tablet is medicine which helps treat many parasitic worm infections. It kills and stops the further growth of parasites causing the infection. This medicine usually makes you feel better quite quickly. However, you should continue taking it as long as it is prescribed even when you feel better, to make sure that all parasites are killed and do not become resistant. This medicine is generally safe to use while pregnant or breastfeeding, but you should ask your doctor.
Unicarbazan 50 mg/1.25 mg Tablet may cause excessive drowsiness with alcohol.
Information regarding the use of Unicarbazan 50 mg/1.25 mg Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Unicarbazan 50 mg/1.25 mg Tablet during breastfeeding is not available. Please consult your doctor.
Unicarbazan 50 mg/1.25 mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Unicarbazan 50 mg/1.25 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Unicarbazan 50 mg/1.25 mg Tablet may not be needed in these patients. Please consult your doctor. Use of Unicarbazan 50 mg/1.25 mg Tablet may cause excessive sleepiness in patients with end stage kidney disease.
There is limited information available on the use of Unicarbazan 50 mg/1.25 mg Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of Unicarbazan 50 mg/1.25 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More